Clinical profile of Org OD 14

Maturitas

Volumn 9, Issue SUPPL. 1, 1987, Pages 3-13

  Tax, L ^a   Goorissen, E M ^a   Kicovic, P M ^a  

^a NV ORGANON   (Netherlands)

Author keywords

Androgenic; Climacteric; Oestrogenic; Org OD 14; Progestational

Indexed keywords

GONADOTROPIN; NEW DRUG; TIBOLONE; CARBOHYDRATE; HORMONE; LIPID; PREGNANE DERIVATIVE; STEROID RECEPTOR;

BONE; BONE ATROPHY; CLIMACTERIUM; DRUG EFFICACY; DRUG THERAPY; ENDOMETRIUM; FEMALE GENITAL SYSTEM; HUMAN; LIBIDO; MENOPAUSE; MOOD; PRIORITY JOURNAL; THERAPY; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMOSTASIS; KINETICS; METABOLISM; OSTEOPOROSIS;

CARBOHYDRATES; CLIMACTERIC; CLINICAL TRIALS; ENDOMETRIUM; FEMALE; HEMOSTASIS; HORMONES; HUMAN; KINETICS; LIPIDS; NORPREGNENES; OSTEOPOROSIS; RECEPTORS, STEROID;

EID: 0023078397     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(87)90038-7     Document Type: Article

References (33)

1. Endometrial hyperplasia in women on cyclic or continuous estrogen regimens
2. A randomized double-blind cross-over trial into the effect of norethisterone on climacteric symptoms and biochemical profiles
3. Endocrinological studies with (7α,17α-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one [(Org OD 14)]
4. A primate model of human postmenopausal hot flushes
5. The use of a new steroid (Org OD 14) in the climacteric syndrome
6. Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women
7. Ovulation-inhibiting properties of Org OD 14
8. Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in post-menopausal and oophorectomized women
9. Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteroporosis
10. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women
11. Assessment of synthetic steroid (Org OD 14): effect on skeletal metabolism by 24-h whole-body retention of diphosphonate
12. Metabolism of synthetic steroids by animals and man
13. Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients
14. Efficacy and safety of Org OD 14 in the treatment of climacteric complaints
15. Effects of Org OD 14 on pituitary and peripheral beta-endorphin in castrated rats and in postmenopausal women
16. Long-term placebo-controlled efficacy and safety study of Org QD 14 in climacteric women
17. Use of Org OD 14 for the treatment of climacteric complaints
18. The effects of oestrogens and progestogens on the postmenopausal endometrium
19. Letter to the Editor
20. A double-blind cross-over study on the effects of Org OD 14 compared to oestradiol valerate and placebo on lipid and carbohydrate metabolism in oophorectomized women
21. Long-term prevention of postmenopausal osteoporosis by oestrogens
22. Lipid metabolic studies in oophorectomized women
23. Pill formulations and their effect on lipid and carbohydrate metabolism
24. The effects of the synthetic steroid Org OD 14 on fibrinolysis and blood lipids in menopausal women
25. Org OD 14: long term effects on serum lipoproteins
26. Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone
27. Triglycerides — main lipid risk factor for cardiovascular disease in women?
28. Risk factors for ischaemic heart disease in men and women
29. Coagulation and fibrinolysis in post-menopausal women treated with Org OD 14
30. Anabolic steroid therapy in arterial disease, a review